Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
Authors:
- 17 February 2022
- journal article
- research article
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 1 (2) , 142-156
Abstract
Some missense gain-of-function mutations in the CACNA1C gene, encoding calcium channel CaV1.2, cause a life-threatening form of long QT syndrome (LQTS) named Timothy syndrome with currently no clinically effective therapeutics. Here we report that pharmacological targeting of sigma non-opioid intracellular receptor 1 (SIGMAR1) can restore electrophysiological function in induced pluripotent stem cell (iPSC)-derived cardiomyocytes generated from patients with Timothy syndrome and two common forms of LQTS, type 1 (LQTS1) and type 2 (LQTS2), caused by missense trafficking mutations in potassium channels. Electrophysiological recordings demonstrate that a Food and Drug Administration (FDA)-approved cough suppressant, dextromethorphan, can be used as an agonist of SIGMAR1 to shorten the prolonged action potential in cardiomyocytes from patients with Timothy syndrome and human cellular models of LQTS1 and LQTS2. When tested in vivo, dextromethorphan also normalized the prolonged QT intervals in a mouse model of Timothy syndrome. Overall, our study demonstrates that SIGMAR1 is a potential therapeutic target for Timothy syndrome and possibly other inherited arrhythmias such as LQTS1 and LQTS2.Keywords
Funding Information
- Columbia University (TRANSFROM TL1 Training program, TRANSFROM TL1 Training program, Core Usage Funding Program)
- MEXT | Japan Society for the Promotion of Science (JSPS Postdoc fellowship)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F31HL142239, R01HL136758, K99/R00HL111345, R01HL138486)
- Leona M. and Harry B. Helmsley Charitable Trust (Helmsley Stem Cell Seed Grant)
This publication has 60 references indexed in Scilit:
- Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndromeNature Medicine, 2011
- Cough management: a practical approachCough, 2011
- Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic CellsJournal of Biological Chemistry, 2011
- Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol HomeostasisJournal of Biological Chemistry, 2011
- Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature, 2011
- Modulation of Angiotensin II–Mediated Cardiac Remodeling by the MEF2A Target Gene Xirp2Circulation Research, 2010
- Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance DatabaseBritish Journal of Clinical Pharmacology, 2010
- Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase IICirculation, 2008
- Mouse models of long QT syndromeThe Journal of Physiology, 2006
- Calcium signalling: dynamics, homeostasis and remodellingNature Reviews Molecular Cell Biology, 2003